Filter
1305
Filtered Results: 1305
Text search:
Global
Commission
on
Drug
Policy
Featured
Recommendations
83
New Publications
394
Language
Document type
No document type
851
Studies & Reports
232
Guidelines
102
Strategic & Response Plan
58
Manuals
42
Situation Updates
8
Fact sheets
8
Training Material
3
Infographics
1
Countries / Regions
Global
50
Nigeria
47
India
45
Western and Central Europe
42
Kenya
37
Uganda
35
Liberia
31
Tanzania
29
Africa
29
Nepal
28
Ghana
27
Malawi
25
Myanmar / Burma
25
Latin America and the Carribbean
25
Sierra Leone
24
South Africa
24
Namibia
23
Zambia
22
Asia
19
Ethiopia
18
Bangladesh
18
Eastern Europe
18
Philippines
17
Lesotho
16
Ukraine
15
Rwanda
14
Indonesia
13
Cambodia
11
South–East Asia Region
10
Russia
9
Congo, Democratic Republic of
7
Burkina Faso
6
Zimbabwe
6
Mozambique
6
West and Central Africa
6
Venezuela
6
Senegal
5
Pakistan
5
Syria
5
Thailand
5
East and Southern Africa
5
Middle East and North Africa
5
South Sudan
4
Germany
4
China
4
North Macedonia
4
Eastern Europe and Central Asia
4
Albania
4
Tajikistan
4
Georgia
4
Afghanistan
3
Brazil
3
Botswana
3
Mexico
3
Western Pacific Region
3
Armenia
3
Laos
3
Moldova
3
Guinea
2
USA
2
Lebanon
2
Sudan
2
Argentina
2
Peru
2
Serbia
2
Colombia
2
Yemen
2
Iran
2
Kyrgyzstan
2
Kazakhstan
2
Vietnam
2
North America
2
Morocco
1
Saudi Arabia
1
Cameroon
1
Haiti
1
Somalia
1
Turkey
1
Egypt
1
Ireland
1
Papua New Guinea
1
Benin
1
Central African Republic
1
Eswatini/ Swaziland
1
Hungary
1
Bolivia
1
Libya
1
Sri Lanka
1
Chile
1
Paraguay
1
Bhutan
1
Palestine
1
Italy
1
Southern Africa
1
Qatar
1
Bulgaria
1
Romania
1
Lithuania
1
Uzbekistan
1
Jamaica
1
Denmark
1
Belgium
1
Maldives
1
Norway
1
Portugal
1
Belarus
1
Authors & Publishers
Publication Years
Category
Countries
525
Public Health
87
Clinical Guidelines
45
Women & Child Health
34
Key Resources
30
Pharmacy & Technologies
15
Capacity Building
4
Toolboxes
HIV
188
Mental Health
148
AMR
84
TB
77
COVID-19
40
Global Health Education
31
Planetary Health
30
Pharmacy
30
NCDs
30
Disability
23
Rapid Response
22
Refugee
18
Conflict
17
Caregiver
17
NTDs
16
Health Financing Toolbox
16
Ebola
12
Polio
6
Natural Hazards
5
Specific Hazards
5
Social Ethics
5
Zika
2
Cholera
1
The power of the Global Drug Policy Index lies in its key objective: to score and
rank how countries are faring in different areas of ... policy as identified in the
UN report ‘What we have learned over the last ten years: A summary of knowledge
acquired and produced by the UN system on drug-related matters’,1 and derived
from the landmark UN System Common Position on Drug
UN, international agencies and experts released a groundbreaking report demanding immediate, coordinated and ambitious action to avert a potentially disastrous drug-resistance crisis.
If no action is taken - warns the UN Ad hoc Interagency Coordin...
10 years after the UN general assembly special session on drugs
The goal of this Global Action Plan is to articulate synergistic actions that will be required to prevent HIVDR from undermining efforts to achieve global targets ... health and HIV, and to provide the most effective treatment to all people living with HIV including adults, key populations, pregnant and breastfeeding women, children and adolescents. The Global Action Plan has five strategic objectives: 1) prevention and response; 2) monitoring and surveillance; 3) research and innovation; 4) laboratory capacity; and 5) governance and enabling mechanisms.
World Drug Report 2018
-2-
The Commission on Macroeconomics and Health (CMH) was established by World Health Organization Director-General Gro Harlem Brundtland in January 2000 to assess the place of health in ... economic development. Although health is widely understood to be both a central goal and an important outcome of development, the importance of investing in health to promote economic development and poverty reduction has been much less appreciated. We have found that extending the coverage of crucial health services, including a relatively small number of specific interventions, to the world’s poor could save millions of lives each year, reduce poverty, spur economic development, and promote global security.
Antimicrobial resistance (AMR) is a global threat that requires urgent collaborative action within and among countries. AMR makes standard treatments ineffective and facilitates the spread of antimicrobial resistant infections rendering communities ...
Mental disorders impose an enormous burden on society, accounting for almost one in three years lived with disability globally. •In addition to their health impact, mental disorders cause a significant economic burden due to lost economic output a...
The Sustainable Development Goals (SDGs) were launched in September 2015, made up of 17 Goals and 169 Targets that set out a plan of action that will shape the mainstream development agenda for the next 15 years1. There has already been much debate about how these Goals will be achieved, but the sig...
The 2020 Report analyzes global health spending for 190 countries from 2000 to 2018 and provides insights as to the health spending trajectory from the MDG era to the SDG era prior to the crisis of 2020. The report shows that ... spending on health continually rose between 2000 and 2018 and reached US$ 8.3 trillion or 10% of global GDP. The data also show that out-of-pocket spending has remained high in low and lower-middle income countries, representing greater than 40% of total health spending in 2018. We also report and summarize the data on expenditures for PHC, as well as by disease and intervention, including for immunization. The report also analyzes the available data on budget allocation in response to the COVID-19 crisis. In addition, we combine World Bank/IMF projections of the macroeconomic and fiscal impact of the crisis with an analysis of the historical determinants of health spending patterns and UHC indicators, and based on this, we draw out the likely implications of 2020 for future health spending, highlighting key policy and monitoring concerns.
World Drug Report 2017
-1-
Accessed: 14.03.2019
Volume 20, September
Global smart update
This third booklet of the World Drug Report 2022 has a dual focus: opioids and cannabis.
The first chapter of the booklet provides an overview of opioids as a group of substances and their patterns of non-medical use at the ... level. It also reviews the latest trends in the global supply of opiates and synthetic opioids and the availability of pharmaceutical opioids for medical consumption. Issues specific to regional patterns and trends in opioid markets are also analysed, including the opioid crisis in North America and in Africa and the Middle East. The chapter also includes a discussion of the potential impact, in the region and worldwide, of changes in opium poppy cultivation and opium production in Afghanistan. reireg
Pakistan Global Antibiotic Resistance Partnership (GARP) was formed in the wake of international and national efforts for AMR curtailment. A group of experts from microbiology, infectious diseases and veterinary medicine ...
Constituting the fourth part of the World Drug Report 2022, this booklet focuses on the market dynamics of various stimulants – cocaine, amphetamines and “ecstasy” – and of NPS.
The first c...
The document, "Progress on the Prevention and Control of Non-Communicable Diseases," reports on global efforts to reduce the impact of NCDs, such a...
In 2015, to advance the global and national response to antimicrobial resistance (AMR), the World Health Assembly issued resolution WHA68.7 calling for all Member States to develop AMR national action plans that address the five objectives of the Wo...
The second edition of the WHPCA Global Atlas of Palliative Care was launched during World Hospice & Palliative Care Day 10 October. The Atlas is an update of the original WHPCA/WHO Global Atlas of P...
The "Global NCD action plan" provides a road map and a menu of policy options for countries to take in order to attain the 9 voluntary global targe...
India contributes to 16% of the global maternal deaths and around 27% of global newborn deaths. Reducing the burden of maternal and newborn mortality and morbidity in urban poor settings today requi...
